(Q45287512)
Statements
1 reference
Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). (English)
1 reference
Emma Morris
1 reference
Stephen Mackinnon
1 reference
1 February 2005
1 reference
1 reference
32
1 reference
1
1 reference
73-83
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference